AMPLY Discovery, an AI-driven drug discovery company, has raised strategic investment from Keeps Biomed, a subsidiary of South Korean company Keeps Biopharma.

The companies have also agreed to explore future collaboration opportunities in oncology, while Dr Oliver Rausch has been appointed chief scientific officer.

Dr Rausch joins from Storm Therapeutics.